CohBar, Inc. (NASDAQ:CWBR) will be hosting a conference call at 5:00 PM eastern time on 16th November 2020, to discuss its 3Q20 financial results with the investment community.
A live webcast with presentations will be available on the Internet by visiting the Company website www.cohbar.com
The participants may dial, (877) 451-6152 Toll Free, (United States) or (201) 389-0879 (International), and the passcode is 13711606 in order to access the live audio call
Earnings Expectation
CohBar, Inc. is expected to report third quarter earnings results, after market close, on Monday 16th November 2020. Analysts polled by Thomson Reuters anticipate third quarter loss of $ 0.07 per share. Looking ahead, the full year loss are expected at $ 0.33 per share.
CohBar, Inc., a clinical stage biotechnology company, engages in the research and development of mitochondria based therapeutics (MBTs) for the treatment of diseases associated with aging and metabolic dysfunction. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, type 2 diabetes mellitus, cancer, atherosclerosis, cardiovascular disease, and neurodegenerative disease, such as Alzheimers disease. Its lead MBT candidate is CB4211, a novel optimized analog of the MOTS-c mitochondrial-derived peptide for the treatment of NASH and obesity.
